Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Synovial tissue biomarker study to guide PVNS management

Official title: Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis

Run by Nantes University Hospital · NCT07503821 · Data updated 2026-11-12

Researchers will collect and analyze synovial tissue from adults with PVNS to see if tissue markers can help tailor treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorNantes University Hospital
Academic / other
Locations3 sites (Lyon and 2 other locations)
StatusRecruiting
StartedOctober 30, 2026
Main results expectedOctober 30, 2030
Study endsOctober 30, 2030
Registry record updatedNovember 6, 2026
Trial IDNCT07503821 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with localized or diffuse PVNS who are referred for therapeutic management and are affiliated with a social security system.

Probably not a fit

Patients who do not have PVNS or who decline participation may not benefit from this biomarker-focused approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, prospective study collects synovial tissue from adults with localized or diffuse PVNS undergoing therapy. The biopsies are used for diagnostic confirmation and research, including histology, immunohistochemistry, and high-throughput analyses. Participants are followed for one year with two visits (6 months and 12 months) to evaluate pain, function, and treatment response, then followed as per routine care for up to four years. The primary goal is to establish a patient biocollection and tissue quality suitable for biomarker discovery, with secondary aims assessing biopsy tolerance, patient acceptability, and the impact of treatments on synovial explants.

Why it matters

Potential benefit: If successful, this approach could enable personalized management of PVNS by using tissue biomarkers to guide therapy choices.

How similar studies have gone: Biomarker and tissue-based studies in PVNS and related synovial diseases have shown potential signals, but this approach remains exploratory in PVNS management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient \>18 years
* Diagnosis of localized or diffuse villonodular synovitis
* Referred for therapeutic management
* Affiliated with or benefiting from a social security scheme

Exclusion Criteria:

* Pregnant women
* Nursing mothers
* Protected patients: patients under guardianship or curatorship, safeguard of justice
* Patients deprived of liberty
* Curative anticoagulation
* Thrombocytopenia \< 50,000 platelets/mm3

Where it's running

  • CHU de Nantes
    Nantes, France
    Recruiting
  • Hospices Civils de Lyon
    Lyon, France
    Not yet recruiting
  • Hôpital Cochin APHP
    Paris, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.